To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Salesforce paid $8 billion for ...

ORLANDO, Fla. — Exagamglogene autotemcel (exa-cel, Casgevy), a CRISPR/Cas9 gene-editing therapy, showed efficacy in children aged 5-11 years with transfusion-dependent beta-thalassemia (TDT) or sickle ...

Salesforce Inc. today released details about its thinking in acquiring Informatica Inc. despite that company’s apparent overlap with Salesforce’s MuleSoft integration subsidiary. Executives said the ...

Shanling’s SCD3.3 treats SACD like it never died—true DSD output, a 212-resistor R2R DAC, tube stage, and enough engineering muscle to shame most “modern” players. Let’s be honest: outside the ...

HIG has signed a definitive agreement to sell its portfolio company Project Informatica to EMK Capital. Founded in 1990, Project Informatica is an operator in the Italian information technology market ...

LMP Capital and Income Fund offers a 9.7% yield, focusing on income generation through a diversified asset mix, but has underperformed recently. SCD trades at an 8.68% discount to NAV, yet remains ...

REDWOOD CITY, Calif.--(BUSINESS WIRE)-- Informatica (NYSE: INFA), a leader in enterprise AI-powered cloud data management, today announced that Yamaha Motor Co., Ltd., a global leader in ...

Informatica (NYSE: INFA), a leader in enterprise AI-powered cloud data management, today announced that Yamaha Motor Co., Ltd., a global leader in transportation equipment manufacturing, has chosen to ...

Behind every successful, modern analytics and AI initiative is a strong data foundation supporting it, comprising of an effective data integration strategy. With data integration in place, enterprises ...

Pfizer’s sickle cell disease (SCD) drug has flunked a key phase 3 test, the latest blow to the pharma’s $5.4 billion acquisition of Global Blood Therapeutics. Pfizer acquired the P-selectin inhibitor, ...